Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: Laplace Early Feasibility Study - Canada [NA]

View source ↗

Summary

A Laplace Interventional, Inc.-sponsored early feasibility study in Canada is currently recruiting for treatment of tricuspid regurgitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Laplace Interventional, Inc | Conditions: Tricuspid Regurgitation | NA | Status: RECRUITING